Follow the Tecan Group AG stock price and the full management transaction log of the company, a listed issuer based in Switzerland. Shares are listed on the CH market, under the supervision of SIX SER. Operating in the Health Care sector, Tecan Group AG has published 12 public disclosures. Market capitalisation: €2.4bn. The latest transaction was disclosed on 16 September 2025 (Sale). All data is accessible without an account.
12
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€10m
12 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Tecan Group AG Buy (bullish), based on 8 analysts. Average price target: CHF 175.48.
26Σ signal
Buys n/a€10m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,430 of 28,752 companies
34.9
score / 100
Value
42
Quality
27
FCF yld4.3%
Earn yld-4.7%
EV/EBITDA·
ROE-8.6%
Gross mgn35%
Net mgn-13%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 September 2025
Declarations12 total
●
Anonymous (Executive member of the board of directors / member of senior management)
Executive member of the board of directors / member of senior management·Executives·
282 shares@ CHF 362.000.0064% mcap100.0% of flowISINISIN CH0012100191SIX:T1N6D00043
12 of 12 declarations
About Tecan Group AG
Tecan Group AG is a company specializing in the development and manufacturing of automation solutions for laboratories. It primarily operates in the healthcare and pharmaceutical sector.